DXS: Funding, Investors & Team (Oct 2026)
DXS is a reputable healthcare IT provider in the UK. Our software solutions, which have been approved by the National Health Service (NHS), support clinical decision-making and optimize medication usage. These solutions effectively improve patient outcomes while being cost-efficient. BestPathway is a comprehensive clinical decision support solution that enhances decision-making within the clinical workflow. It offers a range of tools and features, such as access to high-quality clinical guidance, treatment pathways, and referral forms. Additionally, it serves as a communication tool for various healthcare organizations to deliver updated local information. ExpertCare is an innovative software solution specifically designed for the management of hypertension. It utilizes expert algorithms to provide real-time prescribing advice, aiming to control the patient's blood pressure and align with best evidence medicine guidance for managing any accompanying health conditions. ExpertCare simplifies the complex process of prescribing medication and significantly improves productivity within medical practices.
DXS has raised $30k across 1 funding round on record, the most recent an undisclosed round of $30k announced in Jun 2023.
That round is below the $4.8M median round size for Health Care companies tracked on FundedIQ over the last two years.
DXS Company Profile and Key Stats
Latest funding round on record: Jun 2023.
DXS Funding Rounds
DXS Founders and Leadership Team
No contact details are on record for this team yet.
DXS Funding Compared to Other Health Care Startups
DXS' latest round of $30k is below the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like DXS in Health Care and Elstead
Companies Similar to DXS
52 North Health intends to further develop medical services with a clinical gadget that utilizes man-made…
SageTech is recycling inhalational anaesthetic agents using patented technology to generate significant cost…
Renata Medical develops purposeful medical devices for unmet pediatric needs.
Leo Cancer Care provides a streamlined and effective treatment method that empowers patients and instills…
Neubond develops wearable devices for stroke mobility rehabilitation. These devices provide autonomous…
Silveray develop affordable large-area direct conversion detectors for the X-ray imaging market.
Nebu-Flow is a manufacturer of the next generation of inhaled drugs for patients with respiratory disorders.…
iFAST is addressing the Antimicrobial Susceptibility Testing market, reducing the spread of antimicrobial…
Innovative medical gadgets are created by Creo Medical Limited, situated in Chepstow, South Wales. With a…
TympaHealth has developed the world's first ear and hearing health assessment system. The Tympa system…
NEX Health Intelligence (NEX) is a health-tech business that develops AI-powered software for hospitals to…
Infex Therapeutics acquire, develop and license drugs to treat pandemic infections.
DXS Funding FAQs
What does DXS do?
DXS is a reputable healthcare IT provider in the UK. Our software solutions, which have been approved by the National Health Service (NHS), support clinical decision-making and optimize medication usage. These solutions effectively improve patient outcomes while being cost-efficient. BestPathway is a comprehensive clinical decision support solution that enhances decision-making within the clinical workflow. It offers a range of tools and features, such as access to high-quality clinical guidance, treatment pathways, and referral forms. Additionally, it serves as a communication tool for various healthcare organizations to deliver updated local information. ExpertCare is an innovative software solution specifically designed for the management of hypertension. It utilizes expert algorithms to provide real-time prescribing advice, aiming to control the patient's blood pressure and align with best evidence medicine guidance for managing any accompanying health conditions. ExpertCare simplifies the complex process of prescribing medication and significantly improves productivity within medical practices.
How much funding has DXS raised?
DXS has raised $30k across 1 round on record. The most recent is an undisclosed round of $30k announced in Jun 2023.
When did DXS last raise funding?
DXS' most recent funding round on record is an undisclosed round of $30k, announced in Jun 2023.
Who founded DXS?
FundedIQ lists Rebekah Saunders (Founder) at DXS.
Where is DXS headquartered?
DXS is based in Elstead, Surrey, United Kingdom.
How many employees does DXS have?
DXS is in the 51-100 employee band.
How does DXS' funding compare to other Health Care startups?
DXS' latest round of $30k is below the $4.8M median round size for Health Care companies on FundedIQ across 3,657 tracked companies over the last two years.
About FundedIQ's DXS Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for DXS is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.